Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced topline results from the pivotal ...

WASHINGTON--(BUSINESS WIRE)--Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), and HUMAIN, a Public Investment Fund (PIF) company delivering global full-stack AI solutions, ...

Trane Technologies (NYSE: TT), a global climate innovator, announced the appointment of Gary Guo as Chief Integrated Supply Chain Officer, effective ...

Committed to rewarding loyalty at every stage of the travel journey, today Hilton (NYSE: HLT) announced exciting changes to its award-winning Hilton Honors ...

Marquee’s 19th Brand Signals a Bold Expansion into Lifestyle and Performance NEW YORK--(BUSINESS WIRE)--Marquee Brands, the premier global brand accelerator, today announced the acquisition of Stance, ...

Caleres (NYSE: CAL), a market-leading portfolio of consumer-driven footwear brands, will release its third quarter 2025 financial results before market open ...

LONDON--(BUSINESS WIRE)--EMVCo – the technical body that creates and manages EMV ® Specifications and programmes that enable seamless and secure card-based payments worldwide – has announced that it ...

DUBAI, United Arab Emirates--(BUSINESS WIRE)--All known genetic diseases could be cured within the next decade thanks to major advances in gene editing, a leading scientist told the Dubai Future Forum ...

OSAKA, Japan--(BUSINESS WIRE)--Nitto Denko Corporation (Headquarters: Osaka, Japan; President: Hideo Takasaki; hereafter “Nitto”)(TOKYO:6988) is pleased to announce the extension of its partnership ...

LOS ANGELES--(BUSINESS WIRE)--In a groundbreaking survey of more than 26,000 EV drivers across 30 countries, an overwhelming 77% say persistent myths about electric cars are the single biggest ...

SAVANNAH, Ga.--(BUSINESS WIRE)--Citi Trends, Inc. (NASDAQ: CTRN) today announced plans to release its earnings for the third quarter 2025 before the market opens on Tuesday, December 2, 2025. Citi ...

Built on next-generation CRISPR/Cas and LNP technologies, YolTech Therapeutics is pioneering in vivo gene-editing medicines with the potential for one-time, lifelong benefit. The company’s expanding ...